Home » Newsletters » BioWorld

BioWorld

Jan. 6, 1994

View Archived Issues

CAMBRIDGE BIOTECH SEEKS TO OFFSET LOSSES

TELOR HEDGES ITS BETS ON TEKRON

SEPRACOR TO PURCHASE DRUG MANUFACTURING FACILITY

THERATECH ACQUISITION FORTIFIES PIPELINE

FDA ASKS GENSIA FOR MORE DATA

INFLAZYME'S IPO RAISES CLOSE TO $1M

GLYCOMED'S ASTENOSE REDUCES RESTENOSIS IN BABOONS